4‑Acetylantrocamol LT3 suppresses colorectal cancer growth and metastasis via PI3K/AKT and MAPK pathway modulation.
Saved in:
| Title: | 4‑Acetylantrocamol LT3 suppresses colorectal cancer growth and metastasis via PI3K/AKT and MAPK pathway modulation. |
|---|---|
| Authors: | Lin KT; Department of Radiation Oncology, Cardinal Tien Hospital, New Taipei City 23148, Taiwan, R.O.C., Hsieh YC; School of Pharmacy, National Defense Medical University, Taipei City 11490, Taiwan, R.O.C., Chang PK; School of Medicine, National Defense Medical University, Taipei City 11490, Taiwan, R.O.C., Lai CW; School of Pharmacy, National Defense Medical University, Taipei City 11490, Taiwan, R.O.C., Lee SY; Department of Radiology, Taoyuan Armed Forces General Hospital, Taoyuan 325208, Taiwan, R.O.C., Yen IC; School of Pharmacy, National Defense Medical University, Taipei City 11490, Taiwan, R.O.C. |
| Source: | International journal of molecular medicine [Int J Mol Med] 2026 May; Vol. 57 (5). Date of Electronic Publication: 2026 Mar 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9810955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-244X (Electronic) Linking ISSN: 11073756 NLM ISO Abbreviation: Int J Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
